Herantis Pharma Oyj Overview
Valuation check: HRPMF's ROE is 1532.29%, above the Healthcare sector average of 11.15%.
Get informed when a big investor buys or sells
+ Follow1532.29%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, HRPMF shows a ROE of 1532.29%. That is above the Healthcare sector average of 11.15%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 11.15%. Herantis Pharma Oyj is at 1532.29%, which is higher that average. That is roughly 13637.5% above the sector mean. Use the comparison chart on this page to see how HRPMF stacks up against individual peers as well.
Check the historical chart to see whether HRPMF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Herantis Pharma Oyj with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Herantis Pharma Oyj's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 1532.29%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 11.15%, while HRPMF is at 1532.29%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
